Literature DB >> 16670307

CD4+ T regulatory cell induction and function in transplant recipients after CD154 blockade is TLR4 independent.

Yuan Zhai1, Lingzhong Meng, Feng Gao, Yue Wang, Ronald W Busuttil, Jerzy W Kupiec-Weglinski.   

Abstract

Although the role of CD4(+) T regulatory cells (Treg) in transplantation tolerance has been established, putative mechanisms of Treg induction and function in vivo remain unclear. TLR4 signaling has been implicated in the regulation of CD4(+)CD25(+) Treg functions recently. In this study, we first examined the role of recipient TLR4 in the acquisition of operational CD4(+) Treg following CD154 blockade in a murine cardiac transplant model. Then, we determined whether TLR4 activation in allograft tolerant recipients would reverse alloimmune suppression mediated by CD4(+) Treg. We document that donor-specific immune tolerance was readily induced in TLR4-deficient recipients by a single dose of anti-CD154 mAb, similar to wild-type counterparts. The function and phenotype of CD4(+) Treg in both wild-type and TLR4 knockout long-term hosts was demonstrated by a series of depletion experiments examining their ability to suppress the rejection of secondary donor-type test skin grafts and to inhibit alloreactive CD8(+) T cell activation in vivo. Furthermore, TLR4 activation in tolerant recipients following exogenous LPS infusion in conjunction with donor-type skin graft challenge, failed to break Treg-mediated immune suppression. In conclusion, our data reveals a distinctive property of CD4(+) Treg in tolerant allograft recipients, whose induction and function are independent of TLR4 signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670307     DOI: 10.4049/jimmunol.176.10.5988

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

2.  Toll-like receptor 4 contributes to small intestine allograft rejection.

Authors:  Sheri M Krams; Mouer Wang; Ricardo O Castillo; Takashi Ito; Lori Phillips; John Higgins; Neeraja Kambham; Carlos O Esquivel; Olivia M Martinez
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

3.  The role of T helper cell differentiation in promoting nerve allograft survival with costimulation blockade.

Authors:  Wilson Z Ray; Rahul Kasukurthi; Esther M Papp; Amy M Moore; Andrew Yee; Daniel A Hunter; Nancy L Solowski; Thalachallour Mohanakumar; Susan E Mackinnon; Thomas H Tung
Journal:  J Neurosurg       Date:  2010-02       Impact factor: 5.115

Review 4.  Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.

Authors:  Leslie S Kean; Laurence A Turka; Bruce R Blazar
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

5.  Toll-like receptor 4 gene polymorphism downregulates gene expression and involves in susceptibility to bladder cancer.

Authors:  Yizhen Shen; Meimei Bu; Aimin Zhang; Yi Liu; Baochen Fu
Journal:  Tumour Biol       Date:  2014-12-04

6.  Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide.

Authors:  Stavros Garantziotis; Scott M Palmer; Laurie D Snyder; Tonya Ganous; Benny J Chen; Tie Wang; Donald N Cook; David A Schwartz
Journal:  Transplantation       Date:  2007-10-27       Impact factor: 4.939

7.  The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.

Authors:  Peter Urbanellis; Wendy Shyu; Ramzi Khattar; Jihong Wang; Anna Zakharova; Wei He; Hassan Sadozai; Achiya Z Amir; Itay Shalev; M James Phillips; Oyedele Adeyi; Heather Ross; David Grant; Gary A Levy; Andrzej Chruscinski
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

Review 8.  Mechanisms of regulatory T cell counter-regulation by innate immunity.

Authors:  Heidi Yeh; Daniel J Moore; James F Markmann; James I Kim
Journal:  Transplant Rev (Orlando)       Date:  2013-03-07       Impact factor: 3.943

9.  Inhibition of TLR4 signaling prolongs Treg-dependent murine islet allograft survival.

Authors:  N Zhang; B Krüger; G Lal; Y Luan; A Yadav; W Zang; M Grimm; A M Waaga-Gasser; B Murphy; J S Bromberg; B Schröppel
Journal:  Immunol Lett       Date:  2009-10-29       Impact factor: 3.685

10.  Manipulating IL-2 availability amid presentation of donor MHC antigens suppresses murine alloimmune responses by inducing regulatory T cells.

Authors:  Shuzi Zhang; Hehua Dai; Ni Wan; Yolonda Moore; Zhenhua Dai
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.